IGM Biosciences Inc (NASDAQ:IGMS) shares, rose in value on Thursday, April 16, with the stock price up by 2.52% to the previous day’s close as strong demand from buyers drove the stock to $1.22.
Actively observing the price movement in the last trading, the stock closed the session at $1.19, falling within a range of $1.17 and $1.25. The value of beta (5-year monthly) was 0.57. Referring to stock’s 52-week performance, its high was $22.50, and the low was $0.92. On the whole, IGMS has fluctuated by -3.94% over the past month.
With the market capitalization of IGM Biosciences Inc currently standing at about $72.92 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 9.76M, with a low estimate of 2.5M and a high estimate of 6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.25M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IGMS’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IGMS currently trading nearly 3.35% and -4.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.66, while the 7-day volatility ratio is showing 10.48% which for the 30-day chart, stands at 9.36%. Furthermore, IGM Biosciences Inc (IGMS)’s beta value is 0.59, and its average true range (ATR) is 0.12.
A comparison of IGM Biosciences Inc (IGMS) with its peers suggests the former has fared considerably weaker in the market. IGMS showed an intraday change of 2.52% in last session, and over the past year, it shrunk by -86.74%%.
Data on historical trading for IGM Biosciences Inc (NASDAQ:IGMS) indicates that the trading volumes over the past 10 days have averaged 0.17 and over the past 3 months, they’ve averaged 267.03K. According to company’s latest data on outstanding shares, there are 34.26 million shares outstanding.
Nearly 72.65% of IGM Biosciences Inc’s shares belong to company insiders and institutional investors own 22.72% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.98 million shares as on 2025-03-31, resulting in a short ratio of 4.91. According to the data, the short interest in IGM Biosciences Inc (IGMS) stood at 631.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.15 million. The stock has fallen by -80.03% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IGMS stock heading into the next quarter.
